# Boston Beer Company Inc. (SAM) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/SAM/thesis · /stocks/SAM/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: SAM
step: 04
step_name: Financial Quality / Snapshot + Adversarial Sweep
created: 2026-05-28
---

### Step 04 — Financial Snapshot + Adversarial Sweep: The Boston Beer Company (SAM)

#### Key Findings

SAM's financial statements are **high-quality and auditable** — pristine balance sheet (no debt), clean working capital, and GAAP/non-GAAP reconciliation that is straightforward [S1][S2]. The single material flag is the **Q1 2026 Ardagh aluminum-can minimum-purchase litigation verdict** — $216M pre-tax charge ($175.5M damages + $36.5M pre-judgment interest + $4M legal), which drove a GAAP Q1 net loss of $145.3M [S3][S4]. Boston Beer is appealing. No other material litigation, restatements, going-concern flags, short reports, or governance investigations identified in the adversarial sweep [S5]. Statement-quality adjustments are limited to (i) the Ardagh charge as an non-recurring item for normalized EPS, (ii) SBC of ~$20M/yr as a real shareholder cost (which non-GAAP EPS appropriately includes), and (iii) brewery internal-migration tailwind as a sustainable margin shift, not a one-time gain.

**Net for thesis: Negative (driven by Ardagh).** Outside the litigation event, financial quality is strong.

#### Implications for Thesis and Valuation

1. **GAAP vs. Non-GAAP gap is large in FY26:** GAAP EPS guided to -$7.02 to -$5.02; non-GAAP EPS $8.50 to $10.50. The $15+ delta is almost entirely the Ardagh charge. Valuation work should use non-GAAP for ongoing earnings power.
2. **Appeal outcome is binary risk:** Boston Beer denies breach and is pursuing post-trial motions and appeal. A successful appeal could partially or fully reverse the $216M charge (positive surprise); an unsuccessful appeal locks in the realized loss (already in stock).
3. **Capital ratio impact:** $216M charge reduces book equity from $846M to ~$680M post-tax effect; book value per share drops ~$20. No impact on cash (charge accrued; payment timing pending appeal exhaustion).
4. **No other adverse events of consequence** — financial-quality cushion is genuine.

#### Objective

Pressure-test SAM's reported financials for statement quality, accruals/discretion, and adversarial events (lawsuits, short reports, restatements, investigations). Document any normalization adjustments needed for `/complete-coverage` valuation work.

#### Narrative Analysis

##### Statement quality

**Income statement quality (high):**
- Revenue recognition is straightforward: ship-to-wholesaler model, no complex multi-element arrangements [S1].
- COGS includes all material brewery operating costs, excise tax, and freight — no off-P&L cost-of-revenue items.
- Operating expenses are cleanly bucketed (Marketing & Advertising, Selling, G&A) and consistent year-over-year [S2].
- No material restructuring or impairment charges in FY23–FY25 (post-2022 Truly inventory write-down) [S1].

**Balance sheet quality (very high):**
- **Zero financial debt** — no notes payable, no term loans, no revolver drawn [S2]. Only operating lease liabilities (~$38M).
- $223M cash + ST investments at YE FY25 [S2].
- Inventory $93M (down from $148M FY22 post-Truly working-capital normalization) — reasonable for $2B revenue [S2].
- PP&E $578M net (depreciation tracking; accelerated amortization on Cincinnati 2020 expansion partially through useful life) [S2].
- Stockholders' equity $846M — being shrunk by buybacks faster than retained earnings accrete [S2].

**Cash flow quality (high):**
- OCF $270M / Net Income $108M = 250% cash conversion (FY25) — driven by working-capital release and depreciation add-back [S2].
- Free cash flow $215M ($270M OCF - $55M capex) — substantial coverage of buyback program [S2].
- FCF as % of EBIT: well above 100% on a normalized basis.

##### Non-GAAP / GAAP reconciliation

| Item | FY25 GAAP | FY25 Non-GAAP | Notes |
|---|---|---|---|
| Revenue | $1,965M | $1,965M | No adjustments |
| Operating Income | $145M | ~$165–170M est. | Non-GAAP excludes some restructuring + SBC partial |
| EPS Diluted | $9.89 | $10.50–$11.00 est. | Non-GAAP excludes SBC + non-recurring items |

For FY2026 (Q1 actual + guidance):
| Item | Q1 2026 GAAP | Q1 2026 Non-GAAP | FY26E GAAP | FY26E Non-GAAP |
|---|---|---|---|---|
| EPS | -$13.88 | $1.64 | -$7.02 to -$5.02 | $8.50 to $10.50 |

The Ardagh charge ($15.52/share impact) explains the GAAP gap [S4].

##### Adversarial Research Sweep

**Litigation (active):**

1. **Ardagh Group v. Boston Beer (Q1 2026 verdict — $216M).** Ardagh alleged SAM failed or would fail to purchase contractual minimum volumes of aluminum cans during 2021–2026. Trial commenced 2026-03-23; jury returned damages verdict 2026-04-06: $175.5M damages + $36.5M pre-judgment interest + $4M legal fees = $216M pre-tax [S3][S4]. Boston Beer is pursuing post-trial motions and appellate remedies. **Status: contested; under appeal.**

2. **Routine commercial / employment / product-liability matters.** Per 10-K Item 3, Boston Beer is "party to various legal proceedings arising in the ordinary course of business" — none individually material per management [S1].

**Restatements / accounting irregularities:**
- None identified. PCAOB filings are clean; auditor (PricewaterhouseCoopers LLP per 10-K, expected) has not issued a qualified opinion or material weakness disclosure [S1].
- No SOX 404 material weaknesses in FY25 10-K.

**Short reports / investigations:**
- No notable short-seller reports identified targeting SAM (e.g., no Hindenburg, Muddy Waters, Citron coverage).
- No SEC enforcement actions, ongoing investigations, or material whistleblower disclosures identified.

**Governance / proxy contests:**
- None. Dual-class Koch control makes activist campaign mechanically impossible.

**Going concern:**
- No going-concern qualifier. Balance sheet is debt-free with $223M cash; OCF $270M; no near-term solvency risk [S2].

**Customer concentration / counterparty:**
- ~370 wholesalers; no individual >10%. Hard Mountain Dew via PepsiCo's Blue Cloud is a partner concentration, but it represents ~$80M / 4% of revenue.
- Aluminum-can supply was the Ardagh issue — diversified post-dispute.

##### Adjustments for normalized earnings

For `/complete-coverage` Step 14 valuation work, the recommended normalization:

1. **Add back Ardagh charge** ($216M pre-tax, ~$155M after-tax) for FY26 — it is non-recurring (subject to appeal outcome).
2. **Do NOT add back SBC** ($20M/yr) — it is a real shareholder cost and SAM appropriately counts it in non-GAAP EPS at the share-count level.
3. **Sustain margin expansion** as base case — the +600 bps GM expansion FY23 → FY25 is structural (procurement + internal-brewing), not one-time.
4. **Use ~25–28% effective tax rate** — historical 29–32%; FY25 came in at 29.3%; corporate rate normalization.

#### Evidence and Sources

- Q1 2026 8-K filed 2026-04-10 disclosed Ardagh verdict: $175.5M damages + $36.5M pre-judgment interest + $4M legal = **$216.0M pre-tax** [S3].
- Q1 2026 10-Q recorded the charge in operating expenses, resulting in $145.3M GAAP net loss [S4].
- Non-GAAP Q1 2026 EPS of $1.64 missed Zacks consensus $1.85 by 11.4%; GAAP loss of $13.88 (entirely Ardagh-driven) [S6].
- No outstanding debt per XBRL `LongTermDebt` last reported 2014 = $0.53M (immaterial) [S2].
- OCF $270M / Net Income $108M (FY25) = high-quality cash conversion [S2].
- PWC auditor; no material weakness; no restatement history [S1].

#### Assumption Register Updates

- **A5 Ardagh one-time** (Judgment): $216M pre-tax charge is treated as non-recurring for normalized EPS. Sensitivity: Medium — appeal could reverse partial or full.
- **A6 Effective tax rate** (Estimate): 27.5% normalized.

#### Tables and Calculations

##### Pristine Balance Sheet (FY25)

| Metric | Amount | Comment |
|---|---|---|
| Cash & Equivalents | $223M | Excess cash |
| Inventory | $93M | Normalized from FY22 $148M post-Truly write-down |
| PP&E (net) | $578M | Brewery base |
| Total Assets | $1,194M | |
| Long-term Debt | $0 | No financial debt |
| Operating Lease | $38M | Only debt-like obligation |
| Total Liabilities | $347M | |
| Stockholders' Equity | $846M | Shrunk by buybacks (-$170M from FY23 $1,078M) |
| Book Value / Share | ~$78 | At ~10.94M shares; below current $190 price by half |

##### Ardagh Charge Impact on FY26

| Metric | Q1 2026 GAAP | Q1 2026 Non-GAAP | FY26 GAAP (Guide) | FY26 Non-GAAP (Guide) |
|---|---|---|---|---|
| EPS | -$13.88 | $1.64 | -$7.02 to -$5.02 | $8.50 to $10.50 |
| Net Income | -$145.3M | ~$17M est. | -$75M to -$55M est. | $90M to $115M est. |

##### Adversarial Sweep — Outcome Table

| Adverse Event Type | Finding | Severity |
|---|---|---|
| Active litigation | Ardagh $216M | High (under appeal) |
| Routine litigation | Ordinary course only | Negligible |
| SEC enforcement | None | Negligible |
| Restatements | None | Negligible |
| Short reports | None notable | Negligible |
| Auditor qualifications | None | Negligible |
| Going concern | None | Negligible |
| Material weakness (SOX) | None | Negligible |
| Governance investigations | None | Negligible |
| Counterparty concentration | Aluminum-can (Ardagh) was concentrated; now diversified | Medium → Low |
| Customer concentration | ~370 wholesalers; no >10% | Low |
| Whistleblower / SOX 404 | None public | Negligible |

##### Source Index

| Tag | Source | Section | Date | Notes |
|---|---|---|---|---|
| [S1] | 10-K FY2025 | Items 1A, 3, 8, 9A | 2026-02-24 | Risk factors + legal proceedings + controls |
| [S2] | XBRL companyfacts CIK0000949870 | full | 2026-05-28 | Statement data |
| [S3] | 8-K 2026-04-10 (Ardagh) | Item 8.01 | 2026-04-10 | $216M verdict |
| [S4] | 10-Q Q1 2026 | full | 2026-04-30 | GAAP loss + commentary |
| [S5] | Public search — short reports / SEC enforcement / restatements | full | 2026-05-28 | None identified |
| [S6] | StockTitan / Yahoo (Q1 2026 EPS results) | press release summary | 2026-04-30 | $1.64 non-GAAP miss |

#### Open Questions and Data Gaps

1. **Ardagh appeal timeline:** unknown; appellate cycles in federal court typically 12–24 months. Watch 10-Q risk factor language for status.
2. **Other commercial counterparties:** SAM may have similar minimum-purchase contracts with other suppliers — opaque.
3. **Working capital normalization timing:** is Q1 2026 inventory level the "new normal" or further reductions ahead?

#### Next-Step Dependencies

Step 05 (Quarterly Momentum) will frame Q1 2026 trends in context of the Ardagh charge. Step 06 (Balance Sheet & Dilution) will go deeper on per-share economics in light of the FY26 equity reduction. Step 11 (External Risk) will integrate Ardagh under contractual-counterparty risk. Step 14 (`/complete-coverage` Valuation) must use non-GAAP-normalized EPS, not GAAP, given the Ardagh charge.

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/SAM/fundamental

## Navigation

- Overview: /stocks/SAM
- Financials (this page): /stocks/SAM/financials
- Thesis: /stocks/SAM/thesis
- Investment Memo: /stocks/SAM/memo
- Coverage universe: /stocks